Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 3
1951 2
1954 1
1955 2
1956 3
1958 1
1959 1
1961 1
1965 2
1966 2
1967 2
1969 2
1970 2
1971 1
1972 2
1973 6
1974 2
1975 5
1976 1
1977 2
1978 1
1979 1
1980 5
1981 1
1982 2
1983 1
1984 2
1985 4
1986 5
1987 1
1988 2
1989 3
1990 6
1991 7
1992 8
1993 14
1994 9
1995 13
1996 9
1997 11
1998 13
1999 8
2000 11
2001 5
2002 13
2003 29
2004 21
2005 33
2006 32
2007 40
2008 31
2009 51
2010 67
2011 82
2012 106
2013 115
2014 127
2015 140
2016 157
2017 223
2018 237
2019 272
2020 378
2021 413
2022 281
Text availability
Article attribute
Article type
Publication date

Search Results

2,729 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial.
Zi W, Qiu Z, Li F, Sang H, Wu D, Luo W, Liu S, Yuan J, Song J, Shi Z, Huang W, Zhang M, Liu W, Guo Z, Qiu T, Shi Q, Zhou P, Wang L, Fu X, Liu S, Yang S, Zhang S, Zhou Z, Huang X, Wang Y, Luo J, Bai Y, Zhang M, Wu Y, Zeng G, Wan Y, Wen C, Wen H, Ling W, Chen Z, Peng M, Ai Z, Guo F, Li H, Guo J, Guan H, Wang Z, Liu Y, Pu J, Wang Z, Liu H, Chen L, Huang J, Yang G, Gong Z, Shuai J, Nogueira RG, Yang Q; DEVT Trial Investigators. Zi W, et al. Among authors: peng m. JAMA. 2021 Jan 19;325(3):234-243. doi: 10.1001/jama.2020.23523. JAMA. 2021. PMID: 33464335 Free PMC article. Clinical Trial.
Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.
Cong K, Peng M, Kousholt AN, Lee WTC, Lee S, Nayak S, Krais J, VanderVere-Carozza PS, Pawelczak KS, Calvo J, Panzarino NJ, Turchi JJ, Johnson N, Jonkers J, Rothenberg E, Cantor SB. Cong K, et al. Among authors: peng m. Mol Cell. 2021 Aug 5;81(15):3128-3144.e7. doi: 10.1016/j.molcel.2021.06.011. Epub 2021 Jul 2. Mol Cell. 2021. PMID: 34216544 Free PMC article.
Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.
Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo Y, Ren D, Hua Y, Yu B, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, Li Y, Xiong W, Zeng Z. Wei X, et al. Among authors: peng m. Mol Cancer. 2021 Jan 4;20(1):7. doi: 10.1186/s12943-020-01288-1. Mol Cancer. 2021. PMID: 33397409 Free PMC article. Review.
KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target.
Wei Y, Ren X, Galbo PM Jr, Moerdler S, Wang H, Sica RA, Etemad-Gilbertson B, Shi L, Zhu L, Tang X, Lin Q, Peng M, Guan F, Zheng D, Chinai JM, Zang X. Wei Y, et al. Among authors: peng m. Sci Immunol. 2021 Jul 9;6(61):eabf9792. doi: 10.1126/sciimmunol.abf9792. Sci Immunol. 2021. PMID: 34244312
Integrative Analyses of Genes Associated with Hashimoto's Thyroiditis.
Qiu K, Li K, Zeng T, Liao Y, Min J, Zhang N, Peng M, Kong W, Chen LL. Qiu K, et al. Among authors: peng m. J Immunol Res. 2021 Aug 28;2021:8263829. doi: 10.1155/2021/8263829. eCollection 2021. J Immunol Res. 2021. PMID: 34493981 Free PMC article.
2,729 results